Hyper-O-GlcNAcylation induces cisplatin resistance via regulation of p53 and c-Myc in human lung carcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hyper-O-GlcNAcylation induces cisplatin resistance via regulation of p53 and c-Myc in human lung carcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-31
DOI
10.1038/s41598-017-10886-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes inO-LinkedN-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells
- (2016) Rafaela Muniz de Queiroz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Roles of Post-translational Modifications in the Context of Protein Interaction Networks
- (2015) Guangyou Duan et al. PLoS Computational Biology
- Cancer Metabolism and ElevatedO-GlcNAc in Oncogenic Signaling
- (2014) Zhiyuan Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- O-GlcNAcylation: The Sweet Side of the Cancer
- (2014) Rafaela Muniz de Queiroz et al. Frontiers in Oncology
- Cell diameter measurements obtained with a handheld cell counter could be used as a surrogate marker of G2/M arrest and apoptosis in colon cancer cell lines exposed to SN-38
- (2013) Makiko Tahara et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- O-GlcNAc Transferase Integrates Metabolic Pathways to Regulate the Stability of c-MYC in Human Prostate Cancer Cells
- (2013) H. M. Itkonen et al. CANCER RESEARCH
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
- (2013) Lei S. Qi et al. CELL
- Hyper-O-GlcNAcylation Is Anti-apoptotic and Maintains Constitutive NF-κB Activity in Pancreatic Cancer Cells
- (2013) Zhiyuan Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Global analysis of phosphorylation and ubiquitylation cross-talk in protein degradation
- (2013) Danielle L Swaney et al. NATURE METHODS
- CRISPR interference (CRISPRi) for sequence-specific control of gene expression
- (2013) Matthew H Larson et al. Nature Protocols
- Carboplatin- or Cisplatin-Based Chemotherapy in First-Line Treatment of Small-Cell Lung Cancer: The COCIS Meta-Analysis of Individual Patient Data
- (2012) Antonio Rossi et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic targets in cancer cell metabolism and autophagy
- (2012) Heesun Cheong et al. NATURE BIOTECHNOLOGY
- Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease
- (2011) Gerald W. Hart et al. Annual Review of Biochemistry
- O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy
- (2011) Wenyi Mi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- TP53 Mutations in Nonsmall Cell Lung Cancer
- (2011) Akira Mogi et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Site-specific interplay between O-GlcNAcylation and phosphorylation in cellular regulation
- (2010) Ping Hu et al. FEBS LETTERS
- Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1
- (2010) S A Caldwell et al. ONCOGENE
- Myc-regulated microRNAs attenuate embryonic stem cell differentiation
- (2009) Chin-Hsing Lin et al. EMBO JOURNAL
- First- and second-line therapy for advanced nonsmall cell lung cancer
- (2009) J-P. Sculier et al. EUROPEAN RESPIRATORY JOURNAL
- Screening-based discovery of drug-likeO-GlcNAcase inhibitor scaffolds
- (2009) Helge C. Dorfmueller et al. FEBS LETTERS
- Caspases in apoptosis and beyond
- (2008) J Li et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started